Uganda says drug firms block less-expensive generics

06/19/2013 | AllAfrica Global Media

A senior Ugandan health official alleged that strict enforcement of international patent protections would prevent thousands from gaining access to live-saving drugs for such diseases as malaria, tuberculosis and HIV/AIDS. Government medical adviser Denis Kibira charged that global pharmaceutical firms want to roll back intellectual-property provisions that allow for production of cheaper generic medicines to deal with public health crises.

View Full Article in:

AllAfrica Global Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA